Research Article
Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial
Gabriel Bastiena Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada;b Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada
https://orcid.org/0000-0002-7969-9998View further author information
, BSchttps://orcid.org/0000-0002-7969-9998View further author information, Anita Abbouda Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada;b Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canadahttps://orcid.org/0000-0002-9356-9233View further author information
https://orcid.org/0000-0002-9356-9233View further author information, Christina McAnultya Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada;b Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canadahttps://orcid.org/0000-0003-2787-2792View further author information
, MSchttps://orcid.org/0000-0003-2787-2792View further author information, Laurent Elkriefa Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada;b Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canadahttps://orcid.org/0000-0002-2260-4433View further author information
, MD, MSchttps://orcid.org/0000-0002-2260-4433View further author information, Omar Ledjiarc Unité de recherche clinique appliquée, Centre hospitalier universitaire Ste-Justine, Montréal, Québec, Canadahttps://orcid.org/0000-0003-0296-7568View further author information
, MSchttps://orcid.org/0000-0003-0296-7568View further author information, M. Eugenia Sociasd British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada;e Department of Medicine, Faculty of Medicine, University of British Columbia, University of British Columbia, Vancouver, British Columbia, Canadahttps://orcid.org/0000-0003-2556-7049View further author information
, MD, MSchttps://orcid.org/0000-0003-2556-7049View further author information, Bernard Le Follf Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Center for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada;g Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada;h Department of Pharmacology and Toxicology, Faculty of Medicine, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada;i Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada;j Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canadahttps://orcid.org/0000-0002-6406-4973View further author information
, MD, PhDhttps://orcid.org/0000-0002-6406-4973View further author information, Anees Bahjik Department of Medicine and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canadahttps://orcid.org/0000-0002-3490-314XView further author information
, MDhttps://orcid.org/0000-0002-3490-314XView further author information, Suzanne Brissetteb Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada;l Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canadahttps://orcid.org/0000-0001-8505-964XView further author information
, MDhttps://orcid.org/0000-0001-8505-964XView further author information, Stéphanie Marsanb Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, Canada;l Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canadahttps://orcid.org/0000-0002-9737-6818View further author information
, MDhttps://orcid.org/0000-0002-9737-6818View further author information & Didier Jutras-Aswada Department of Psychiatry and Addictology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada;b Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec, CanadaCorrespondence[email protected]
https://orcid.org/0000-0002-8474-508XView further author information
, MD, MSchttps://orcid.org/0000-0002-8474-508XView further author information show all